|
Huntington's disease
Citations 31-40 of 49 total displayed.
|
Past content
(since Aug 2001):
|
- ARTICLES
Assessment of cognition in Parkinson’s disease
- J. Marinus, M. Visser, N. A. Verwey, F. R.J. Verhey, H. A.M. Middelkoop, A. M. Stiggelbout, and J. J. van Hilten
Neurology 2003; 61: 1222-1228.
[Abstract]
[Full text]
[PDF]
- ARTICLES
Huntington’s disease: Clinical correlates of disability and progression
- N. Mahant, E.A. McCusker, K. Byth, and S. Graham
Neurology 2003; 61: 1085-1092.
[Abstract]
[Full text]
[PDF]
- BRIEF COMMUNICATIONS
Huntington’s disease–like 2 can present as chorea-acanthocytosis
- R. H. Walker, A. Rasmussen, D. Rudnicki, S. E. Holmes, E. Alonso, T. Matsuura, T. Ashizawa, B. Davidoff-Feldman, and R. L. Margolis
Neurology 2003; 61: 1002-1004.
[Abstract]
[Full text]
[PDF]
- CLINICAL/SCIENTIFIC NOTES
Creatine therapy for Huntington’s disease: Clinical and MRS findings in a 1-year pilot study
- S.J. Tabrizi, A.M. Blamire, D.N. Manners, B. Rajagopalan, P. Styles, A.H.V. Schapira, and T.T. Warner
Neurology 2003; 61: 141-142.
[Full text]
[PDF]
- BRIEF COMMUNICATIONS
IV amantadine improves chorea in Huntington’s disease An acute randomized, controlled study
- C. Lucetti, P. Del Dotto, G. Gambaccini, G. Dell’ Agnello, S. Bernardini, G. Rossi, L. Murri, and U. Bonuccelli
Neurology 2003; 60: 1995-1997.
[Abstract]
[Full text]
[PDF]
- ARTICLES
Evidence for more widespread cerebral pathology in early HD: An MRI-based morphometric analysis
- H. D. Rosas, W. J. Koroshetz, Y. I. Chen, C. Skeuse, M. Vangel, M. E. Cudkowicz, K. Caplan, K. Marek, L. J. Seidman, N. Makris, B. G. Jenkins, and J. M. Goldstein
Neurology 2003; 60: 1615-1620.
[Abstract]
[Full text]
[PDF]
- CLINICAL/SCIENTIFIC NOTES
Early Huntington disease prenatal diagnosis by maternal semiquantitative fluorescent-PCR
- M.C. González-González, M.J. Trujillo, M. Rodríguez de alba, and C. Ramos
Neurology 2003; 60: 1214-a-1215-a.
[Full text]
[PDF]
- ARTICLES
Predictors of nursing home placement in Huntington disease
- V.L. Wheelock, T. Tempkin, K. Marder, M. Nance, R.H. Myers, H. Zhao, E. Kayson, C. Orme, and I. Shoulson
Neurology 2003; 60: 998-1001.
[Abstract]
[Full text]
[PDF]
- CLINICAL/SCIENTIFIC NOTES
Minocycline for Huntington’s disease: An open label study
- Raphael M. Bonelli, Clemens Heuberger, and Franz Reisecker
Neurology 2003; 60: 883-884.
[Full text]
[PDF]
- BRIEF COMMUNICATIONS
Relationship between CAG repeat length and late-stage outcomes in Huntington’s disease
- K. Marder, S. Sandler, A. Lechich, J. Klager, and S.M. Albert
Neurology 2002; 59: 1622-1624.
[Abstract]
[Full text]
[PDF]
|
|
